Adcendo funding boosts antibody-drug conjugates development
Funds will be used to ensure the wider pan-sarcoma development of lead candidate uPARAP
Read More
Tag: adcendo
- Fabentech secures French approval for Ricimed antidote
- Oxford Drug Design reports major in vivo milestone for novel cancer therapy
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
